Finance

Lists
BRTX:NASDAQ
BioRestorative Therapies Inc
USD 1,87
-1,06%
(-0,020) 1D
9 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BRTX...
Open
USD 1,92
High
USD 1,95
Low
USD 1,85
Mkt. cap
2,58 m
Avg. vol.
221,92 k
Volume
18,44 k
52-wk high
USD 34,60
52-wk low
USD 1,75
EPS
-USD 21,76
Beta
0,85
Shares outstanding
1,38 m
No. of employees
14
Open
USD 1,92
High
USD 1,95
Low
USD 1,85
Mkt. cap
2,58 m
Avg. vol.
221,92 k
Volume
18,44 k
52-wk high
USD 34,60
52-wk low
USD 1,75
EPS
-USD 21,76
Beta
0,85
Shares outstanding
1,38 m
No. of employees
14
News stories
From web sources and news partners
About BioRestorative Therapies Inc
CEO-
Employees14
Founded1997
Headquarters-
Sector-
Websitebiorestorative.com
Analyst ratings
Based on 1 analyst giving stock ratings to BRTX in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for BRTX in the last 3 months
Highest
Current USD 1,87
(-100,00%)
Average
(-100,00%)
Lowest
(-100,00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Okunewitch
Maxim Group
Hold
Downgraded
-
-
10/06/2026
Jonathan Aschoff
Roth MKM
Buy
Maintained
USD 15,00
+702,1%
04/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
303,30 k
11,80 k
19,60 k
23,17 k
Cost of goods sold
8,73 k
10,57 k
1,64 k
7,38 k
Cost of revenue
8,73 k
10,57 k
1,64 k
7,38 k
Research and development expenses
2,23 m
2,59 m
2,63 m
1,93 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,37 m
1,12 m
1,22 m
1,48 m
Operating expense
3,60 m
3,71 m
3,84 m
3,40 m
Total operating expenses
3,61 m
3,72 m
3,84 m
3,41 m
Operating income
-3,31 m
-3,71 m
-3,83 m
-3,39 m
Other non operating income
575,11 k
612,99 k
583,08 k
1,23 m
EBT including unusual items
-2,66 m
-3,04 m
-3,21 m
-2,15 m
EBT excluding unusual items
-2,66 m
-3,04 m
-3,21 m
-2,15 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2,66 m
-3,04 m
-3,21 m
-2,15 m
Net profit margin
-875,79%
-25 748,11%
-16 365,49%
-9 298,25%
Earnings per share
-6,00
-6,60
-6,40
-2,40
Interest and investment income
73,92 k
57,74 k
34,59 k
5,48 k
Interest expense
-
-
-
-
Net interest expenses
73,92 k
57,74 k
34,59 k
5,48 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-3,25 m
-3,66 m
-3,77 m
-3,33 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme